About T-box transcription factor TBX6
T-box transcription factor TBX6 (TBX6) is a protein
from Homo sapiens identified by UniProt accession
O95947, 436 residues long.
MolForge cross-references it against 0 known binders and
199 disease associations.
Target properties
| Protein name | T-box transcription factor TBX6 |
| UniProt accession | O95947 |
| Gene | TBX6 |
| Organism | Homo sapiens |
| Length | 436 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (199)
Diseases linked to this target (Open Targets).
- autosomal dominant spondylocostal dysostosis · score 0.71
- scoliosis · score 0.52
- genetic disorder · score 0.45
- eosinophil count · score 0.30
- mean corpuscular volume · score 0.30
- erythrocyte count · score 0.29
- mean corpuscular hemoglobin · score 0.28
- mean corpuscular hemoglobin concentration · score 0.28
- hemoglobin measurement · score 0.28
- hematocrit · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95947-F1 | alphafold | PREDICTED | 64.63 | — |
Amino-acid sequence (436 residues)
MYHPRELYPS LGAGYRLGPA QPGADSSFPP ALAEGYRYPE LDTPKLDCFL SGMEAAPRTL AAHPPLPLLP PAMGTEPAPS APEALHSLPG VSLSLENREL WKEFSSVGTE MIITKAGRRM FPACRVSVTG LDPEARYLFL LDVIPVDGAR YRWQGRRWEP SGKAEPRLPD RVYIHPDSPA TGAHWMRQPV SFHRVKLTNS TLDPHGHLIL HSMHKYQPRI HLVRAAQLCS QHWGGMASFR FPETTFISVT AYQNPQITQL KIAANPFAKG FRENGRNCKR ERDARVKRKL RGPEPAATEA YGSGDTPGGP CDSTLGGDIR ESDPEQAPAP GEATAAPAPL CGGPSAEAYL LHPAAFHGAP SHLPTRSPSF PEAPDSGRSA PYSAAFLELP HGSGGSGYPA APPAVPFAPH FLQGGPFPLP YTAPGGYLDV GSKPMY
Explore T-box transcription factor TBX6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets